Skip to main content

Find Clinical Trials

Home
Conditions
Germline BRCA-mutated HER2-negative Breast Cancer

Clinical trial condition

Germline BRCA-mutated HER2-negative Breast Cancer

Explore clinical trials studying Germline BRCA-mutated HER2-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Germline BRCA-mutated HER2-negative Breast Cancer trial results

Recruiting

Fluzoparib Combined With Camrelizumab for Neoadjuvant Treatment of Embryogenic BRCA Mutation HER2 Negative Breast Cancer: an Open, Single Arm, Multicenter Study

NCT05576389

Conditions: Germline BRCA-mutated HER2-negative Breast Cancer
Locations: Breast Cancer, Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details